DTLGX
Price
$51.23
Change
-$1.20 (-2.29%)
Updated
Nov 13 closing price
Net Assets
286.88M
VIGAX
Price
$248.57
Change
-$5.44 (-2.14%)
Updated
Nov 13 closing price
Net Assets
357.2B
Interact to see
Advertisement

DTLGX vs VIGAX

Header iconDTLGX vs VIGAX Comparison
Open Charts DTLGX vs VIGAXBanner chart's image
Wilshire Large Company Growth Invmt
Price$51.23
Change-$1.20 (-2.29%)
VolumeN/A
Net Assets286.88M
Vanguard Growth Index Admiral
Price$248.57
Change-$5.44 (-2.14%)
VolumeN/A
Net Assets357.2B
DTLGX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
DTLGX vs. VIGAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTLGX is a Hold and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 357B vs. DTLGX (287M). VIGAX pays higher dividends than DTLGX: VIGAX (0.40) vs DTLGX (0.00). DTLGX was incepted earlier than VIGAX: DTLGX (33 years) vs VIGAX (25 years). DTLGX (1.32) is less costly to investors than VIGAX (0.05). DTLGX is a more actively managed with annual turnover of: 66.00 vs. VIGAX (11.00). DTLGX has a lower initial minimum investment than VIGAX: DTLGX (1000) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 20.72 vs. DTLGX (6.82). VIGAX return over 5 years is better than : 107.24 vs. DTLGX (0.30).
DTLGXVIGAXDTLGX / VIGAX
Total Expense Ratio1.300.052,600%
Annual Report Gross Expense Ratio1.320.052,640%
Fund Existence33 years25 years-
Gain YTD20.40020.258101%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets287M357B0%
Annual Yield % from dividends0.000.40-
Returns for 1 year6.8220.7233%
Returns for 3 years62.16114.6254%
Returns for 5 years0.30107.240%
Returns for 10 years26.09367.757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTDX150.19-1.85
-1.22%
Franklin Biotechnology Discovery C
HGXYX16.61-0.25
-1.48%
Hartford Global Impact Y
TRZLX46.20-0.70
-1.49%
T. Rowe Price US Large-Cap Core Z
QAACX52.34-0.90
-1.69%
Federated Hermes MDT All Cap Core A
ZVGNX57.61-2.76
-4.57%
Zevenbergen Genea Investor